Comments Senators company to study a new connection using antidepressants during pregnancy with severe lung disorders in infants
Newport Beach, CA (PRWeb) January 16, 2012
tags as part of an ongoing investigation of legal claims in a certain antidepressant medications that can cause birth defects and other negative consequences for children whose mothers taking drugs during pregnancy, Senators (ret.) Company, LLP, said today on a new study in the British Medical Journal, which contributes to the growing scientific evidence that some drugs can greatly increase the risk of serious lung disease in newborns.
Tags: In the new study, researchers examined more than 1.6 million births from 1996 to 2007 in some Scandinavian countries. After checking several risk factors, the researchers found a strong relationship between exposure to SSRIs in late pregnancy and persistent pulmonary hypertension of the newborn. Disorder, also known as PPHN is a rare disease, but dangerous to life, in which the system does not provide newborn blood circulation in the lungs. The study shows that use of SSRI drugs in late stages of pregnancy may double the risk of PPHN.
Tags: Depression is more common in women of childbearing years and it is estimated that about 13% of women in the United States taken antidepressants during pregnancy. In the last 20 years, which is a special class of antidepressants known as selective serotonin reuptake (SSRIs) became the basis of treatment of women with depression. These include Zoloft (sertraline), Lexapro (escitalopram), paroxetine, Prozac (fluoxetine), Celexa (citalopram), Symbyax (olanzapine and fluoxetine) and Effexor (venlafaxine), among others. However, concerns remain about the safety of SSRIs on the developing fetus.
Tags: Due to ethical issues, the FDA requires drug manufacturers to carry out pre-market clinical drug studies in pregnant women, and instead relies primarily on animal testing may not reflect the actual risk to humans. As a result, the evidence of SSRI birth defects is based on post-marketing studies. A number of studies within and outside the U.S., in various SSRIs during pregnancy is performed and the results of this research are passionate debate on pharmaceutical companies, researchers and medical community. This latest research seems to address some limitations of previous studies and increases the demand for people who are trying to hold manufacturers responsible for injuries PPHN SSRIs, said Thomas M. Moore, Managing Partner, Senators (ret.).? ?
Tags: Over the past few years, the FDA issued several warnings on the potential impact of SSRIs on the developing fetus and requires stronger warnings on some products. Catch-22 problem with this is that depression and bipolar disease are major health problems and require doctors to prescribe antidepressants, although the real benefits of the drug outweigh its risks, says a former California State Senator Martha Escutia And, a founding member of senators and former President of the State California Senate Health Committee. However, it is equally important that physicians accurate information from drug manufacturers, what is a real danger that those women who are or may be pregnant can make an informed decision based its own unique circumstances.
Tags: Senator (ret.) Company, LLP provides legal representation to consumers injured by an integrated and common approach, which combines many years of experience in the legal arena and the court complex. Lawyers firm Senators (ret.), LLP is committed to providing clients with practical and effective solutions to complex legal problems. We place emphasis on integrity, professionalism, communication and responsiveness to customer needs. Tags ###
clear = “all”
